Primary breast diffuse large B-cell lymphoma shows an activated B-cell-like phenotype

Annals of Diagnostic Pathology
Dan LiPeng Xie

Abstract

Patients with diffuse large B-cell lymphoma (DLBCL) can be divided into germinal center B-cell-like subtype (GCB-DLBCL) and activated B-cell-like type (ie non-GCB-DLBCL) and with a prognostic value based on the cell of origin of the tumor as determined by microarray analysis, as well as by immunostain algorithms. To stratify primary breast DLBCL, according to immunostain algorithms of Hans, Choi, and Meyer (Tally), the reason why primary breast DLBCL possesses a poor clinical outcome was further elucidated. Twenty-two cases of primary breast DLBCL, diagnosed according to the 2008 World Health Organization classification of tumors of hematopoietic and lymphoid tissues, were retrospectively studied. Immunochemical study was performed, and follow-up information was analyzed. The histopathologic and immunophenotypic features of all cases were summarized. Among these 22 cases, most (17, 16, and 17, respectively) were assigned to the activated B-cell-like subtypes, few (5, 6, and 5, respectively) were classified as GCB-DLBCL subtype. Fourteen of these 22 cases expressed high proliferative activity (≥40% Ki-67 labeling). Most primary breast DLBCLs have activated B-cell-like subtype characteristics and high proliferative activity; thes...Continue Reading

References

Oct 31, 2001·Journal of Clinical Pathology·P WindrumG M Markey
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E ZuccaUNKNOWN International Extranodal Lymphoma Study Group
Aug 15, 2003·Leukemia & Lymphoma·D GholamV Ribrag
Oct 20, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sayaka YoshidaMasafumi Abe
Apr 29, 2005·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Masaya UesatoTakenori Ochiai
Jan 25, 2006·American Journal of Hematology·Isao MiyoshiHirokuni Taguchi
Jun 2, 2007·Cancer·Kristen GanjooSandra Horning
Oct 13, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G RyanUNKNOWN International Extranodal Lymphoma Study Group
Dec 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yasodha NatkunamIzidore S Lossos
Jul 3, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G MartinelliF Cavalli
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William W L ChoiWing C Chan
Jun 30, 2010·World Journal of Surgical Oncology·Nicola AveniaFrancesco Sciannameo
Jul 16, 2010·Pathology, Research and Practice·Dan LiCan Mi
Sep 28, 2010·Archives of Gynecology and Obstetrics·Mesut SekerMustafa Benekli
Dec 4, 2010·International Journal of Cancer. Journal International Du Cancer·Ho-Young YhimChang-Yeol Yim
Dec 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul N MeyerDennis D Weisenburger
Apr 2, 2011·Clinical Lymphoma, Myeloma & Leukemia·Shu ZhaoXiao-Chuan Wang

❮ Previous
Next ❯

Citations

Jan 16, 2014·Indian Journal of Surgical Oncology·K N LokeshD Lokanatha
Jun 21, 2013·Hematological Oncology·John F Seymour
Jun 24, 2014·Cancer Treatment Reviews·Chan Y CheahJohn F Seymour
Jan 12, 2016·The American Journal of Surgical Pathology·Kohei TaniguchiTadashi Yoshino
Dec 22, 2017·Oncotarget·Fernando FrancoMargarita Sánchez-Beato
Apr 5, 2017·Journal of the National Cancer Institute·Piers BlomberyJohn F Seymour

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.